Publications Database

Fido A. , Al-Saad S. (2008)

Olanzapine in the treatment of behavioral problems associated with autism: an open-label trial in Kuwait.

Medical Principles and Practice

17(5), pp. 415-418

Read Abstract (New Window)

Frye R. E. et al. (2013)

Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study.

Transcultural Psychiatry

3 e237.

Read Full (New Window)

Gabriels R. L. et al. (2012)

Improving psychiatric hospital care for pediatric patients with autism spectrum disorders and intellectual disabilities.

Autism Research and Treatment

Read Abstract (New Window) Read Full (New Window)

Gabriels R. L. et al. (2012)

Pilot study measuring the effects of therapeutic horseback riding on school-age children and adolescents with autism spectrum disorders.

Research in Autism Spectrum Disorders

6(2), pp. 578-588

Read Abstract (New Window)

Gagliano A. et al. (2004)

Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications.

Journal of Child and Adolescent Psychopharmacology

14(1), pp. 39-47

Read Abstract (New Window)

Gargaro B. et al. (2011)

Autism and ADHD: how far have we come in the comorbidity debate?

Neuroscience and biobehavioral reviews

35(5), pp. 1081-1088.

Read Abstract (New Window)

Geier D. A. , Geier M. R. (2006)

A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders.

Neuroendocrinology Letters

December, 27(6), pp. 833-838

Read Abstract (New Window)

Gerritsen J. (2000)

The effect of Tomatis therapy on children with autism: Eleven case studies.

International Journal of Listening

24(1), pp. 50-68.

Read Abstract (New Window)

Ghaleiha A. et al. (2015)

A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.

Psychiatry Research

Read Abstract (New Window)

Ghaleiha A. et al. (2013)

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

International Journal of Neuropsycholpharmacology

16(4), pp. 783-789.

Read Abstract (New Window)

Ghaleiha A. et al. (2013)

Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: A double-blind, placebo-controlled, randomized trial.

Pediatric Drugs

15(6), pp. 505-514.

Read Abstract (New Window)

Ghanizadeh A. , Sahraeizadeh A. , Berk M. (2014)

A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial.

Child Psychiatry and Human Development

45(2), pp. 185-192.

Read Abstract (New Window)

Goldman S. E. et al. (2009)

Defining the sleep phenotype in children with autism.

Developmental Neuropsychology

34(5), pp. 560-573.

Read Abstract (New Window) Read Full (New Window)

Golubchik P. , Sever J. , Weizman A. (2013)

Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive-hyperactive symptoms: an open-label trial.

Clinical Neuropharmacology

March, 36(2), pp. 37-41.

Read Abstract (New Window)

Golubchik P. , Rapaport M. , Weizman A. (2017)

The effect of methylphenidate on anxiety and depression symptoms in patients with Asperger syndrome and comorbid attention deficit-hyperactivity disorder.

International Clinical Psychopharmacology

September , 32(4), pp. 289-293.

Read Abstract (New Window)

Gordon C. T. et al. (1993)

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

Archives of General Psychiatry

50(6), pp. 441-447.

Read Abstract (New Window)

Gordon C. T. et al. (1992)

Differential response of seven subjects with autistic disorder to clomipramine and desipramine.

American Journal of Psychiatry

149(3), pp. 363-366.

Read Abstract (New Window)

Gringras P. (2000)

Practical paediatric psychopharmacological prescribing in autism: the potential and the pitfalls.

Autism

4(3), pp. 229-247

Read Abstract (New Window)

Handen B. L. , Johnson C. R. , Lubetsky M. J. (2000)

Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.

Journal of Autism and Developmental Disorders

30(3), pp. 245-255

Read Abstract (New Window)

Handen B. L. , Sahl R. , Hardan A. Y. (2008)

Guanfacine in children with autism and/or intellectual disabilities.

Journal of Developmental and Behavioral Pediatrics

29(4), pp. 303-308

Read Abstract (New Window)